Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

Title
Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
Authors
Keywords
-
Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 128, Issue 5, Pages 989-995.e8
Publisher
Elsevier BV
Online
2011-09-29
DOI
10.1016/j.jaci.2011.07.056

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started